103 related articles for article (PubMed ID: 3035749)
21. Effect of indomethacin, aspirin, and acetaminophen on in vitro antiviral and antiproliferative activities of recombinant human interferon-alpha 2a.
Takaoki M; Yamashita Y; Koike K; Matsuda S
J Interferon Res; 1988 Dec; 8(6):727-33. PubMed ID: 3230331
[TBL] [Abstract][Full Text] [Related]
22. Are the acid-labile interferon alpha and interferon omega-1 identical?
Kontsek P; Borecký L; Novák M
Virology; 1991 Mar; 181(1):416-8. PubMed ID: 1994590
[TBL] [Abstract][Full Text] [Related]
23. Effect of hyperthermia on the antiproliferative activities of murine alpha-, beta-, and gamma-interferon: differential enhancement of murine gamma-interferon.
Fleischmann WR; Fleischmann CM; Gindhart TD
Cancer Res; 1986 Jan; 46(1):8-13. PubMed ID: 2998611
[TBL] [Abstract][Full Text] [Related]
24. Interferon-induced growth modulation: low dose maintenance of the antiproliferative response.
Krueger LJ; Terry RW; Sussman AJ; Tate AC; Axelrod DE
J Interferon Res; 1984; 4(1):29-40. PubMed ID: 6715912
[TBL] [Abstract][Full Text] [Related]
25. Establishment of new and replacement World Health Organization International Biological Standards for human interferon alpha and omega.
Meager A; Gaines Das R; Zoon K; Mire-Sluis A
J Immunol Methods; 2001 Nov; 257(1-2):17-33. PubMed ID: 11687235
[TBL] [Abstract][Full Text] [Related]
26. Serum protein masking of the thermal sensitivity of the antiviral activity of purified human beta interferon: implications for clinical studies.
Cook AW; Nidzgorski F; Came P; Mann G; Carter WA; Roane PR
J Biol Response Mod; 1986 Dec; 5(6):499-503. PubMed ID: 3025378
[TBL] [Abstract][Full Text] [Related]
27. A practical cytopathic effect/dye-uptake interferon assay for routine use in the clinical laboratory.
Yousefi S; Escobar MR; Gouldin CW
Am J Clin Pathol; 1985 Jun; 83(6):735-40. PubMed ID: 2988328
[TBL] [Abstract][Full Text] [Related]
28. The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation.
Novick D; Nabioullin RR; Ragsdale W; McKenna S; Weiser W; Garone L; Burkins C; Kim SH; Rubinstein M; Tepper MA; Arulanandam AR
J Interferon Cytokine Res; 2000 Nov; 20(11):971-82. PubMed ID: 11096454
[TBL] [Abstract][Full Text] [Related]
29. Biological activities and receptor binding of two human recombinant interferons and their hybrids.
Meister A; Uzé G; Mogensen KE; Gresser I; Tovey MG; Grütter M; Meyer F
J Gen Virol; 1986 Aug; 67 ( Pt 8)():1633-43. PubMed ID: 3016158
[TBL] [Abstract][Full Text] [Related]
30. [Interferon sensitivity of various cell lines].
Tonew M; Glück B
J Basic Microbiol; 1986; 26(3):173-9. PubMed ID: 3018215
[TBL] [Abstract][Full Text] [Related]
31. Augmented antiproliferative effects of interferons at elevated temperatures against human bladder carcinoma cell lines.
Groveman DS; Borden EC; Merritt JA; Robins HI; Steeves R; Bryan GT
Cancer Res; 1984 Dec; 44(12 Pt 1):5517-21. PubMed ID: 6498814
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic study of a human recombinant interferon (Re-IFN-alpha A) in cynomolgus monkeys by 2'-5' oligoadenylate synthetase assay.
Bannai H; Tatsumi M; Kohase M; Onishi E; Yamazaki S
Jpn J Med Sci Biol; 1985 Jun; 38(3):113-24. PubMed ID: 2999483
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of interferon action: human leukocyte and immune interferons regulate the expression of different genes and induce different antiviral states in human amnion U cells.
Samuel CE; Knutson GS
Virology; 1983 Oct; 130(2):474-84. PubMed ID: 6316641
[TBL] [Abstract][Full Text] [Related]
34. Comparative antiproliferative efficacies of human alpha and gamma interferons.
Rubin BY; Sekar V; Martimucci WA
J Gen Virol; 1983 Aug; 64 (Pt 8)():1743-8. PubMed ID: 6409992
[TBL] [Abstract][Full Text] [Related]
35. Isolation of Daudi cells with reduced sensitivity to interferon. IV. Characterization of clones with altered binding of human interferon alpha subspecies.
Dron M; Tovey MG; Uzé G
J Gen Virol; 1986 Apr; 67 ( Pt 4)():663-9. PubMed ID: 2937878
[TBL] [Abstract][Full Text] [Related]
36. Interferon-gamma is not an antiviral, but a growth-promoting factor for T lymphocytes.
Landolfo S; Gariglio M; Gribaudo G; Jemma C; Giovarelli M; Cavallo G
Eur J Immunol; 1988 Apr; 18(4):503-9. PubMed ID: 2835246
[TBL] [Abstract][Full Text] [Related]
37. High and low potency interferon-alpha subtypes induce (2'-5') oligoadenylate synthetase with similar efficiency.
Goren T; Kapitkovsky A; Kimchi A; Rubinstein M
Virology; 1983 Oct; 130(2):273-80. PubMed ID: 6316631
[TBL] [Abstract][Full Text] [Related]
38. Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta.
Meager A; Das RG
J Immunol Methods; 2005 Nov; 306(1-2):1-15. PubMed ID: 16226271
[TBL] [Abstract][Full Text] [Related]
39. Effect of human fibroblast interferon on the antiviral activity of mammalian cells treated with bleomycin, vincristine, or mitomycin C.
Suhadolnik RJ; Sawada Y; Flick MB; Reichenbach NL; Mosca JD
Cancer Res; 1983 Nov; 43(11):5462-6. PubMed ID: 6193871
[TBL] [Abstract][Full Text] [Related]
40. Interferon-alpha-(IFN) producing CHO cell lines are resistant to the antiproliferative activity of IFN: a correlation with gene expression.
van Heuvel M; Govaert-Siemerink M; Bosveld IJ; Zwarthoff EC; Trapman J
J Cell Biochem; 1988 Dec; 38(4):269-78. PubMed ID: 3241015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
